Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 4516 AL 4530

Intrathecal therapy for cancer and non-cancer pain

Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB.

Pain Physician. 2011 May-Jun;14(3):219-48.

Glut1 deficiency: when to suspect and how to diagnose?

Verrotti A, D'Egidio C, Agostinelli S, Gobbi G.

Eur J Paediatr Neurol. 2012 Jan;16(1):3-9. doi: 10.1016/j.ejpn.2011.09.005. Epub 2011 Oct 1.

Fatty Acid Hydroxylase-Associated Neurodegeneration

Gregory A, Venkateswaran S, Hayflick SJ.

2011 Jun 28 [updated 2018 Sep 27]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity

Dan B, Motta F, Vles JS, Vloeberghs M, Becher JG, Eunson P, Gautheron V, Lütjen S, Mall V, Pascual-Pascual SI, Pauwels P, Røste GK.

Eur J Paediatr Neurol. 2010 Jan;14(1):19-28. doi: 10.1016/j.ejpn.2009.05.002. Epub 2009 Jun 21.

The use of botulinum toxin for the treatment of muscle spasticity in the first 2 years of life

Bakheit AM.

Int J Rehabil Res. 2010 Jun;33(2):104-8. doi: 10.1097/MRR.0b013e32832c1e91.

Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial

Olesch CA, Greaves S, Imms C, Reid SM, Graham HK.

Dev Med Child Neurol. 2010 Jan;52(1):79-86. doi: 10.1111/j.1469-8749.2009.03387.x. Epub 2009 Jul 3.

Neurotoxic and cytotoxic effects of venom from different populations of the Egyptian Scorpio maurus palmatus

Abdel-Rahman MA, Omran MA, Abdel-Nabi IM, Nassier OA, Schemerhorn BJ.

Toxicon. 2010 Feb-Mar;55(2-3):298-306. doi: 10.1016/j.toxicon.2009.08.003. Epub 2009 Aug 11.

Management of spasticity after spinal cord injury: current techniques and future directions

Elbasiouny SM, Moroz D, Bakr MM, Mushahwar VK.

Neurorehabil Neural Repair. 2010 Jan;24(1):23-33. doi: 10.1177/1545968309343213. Epub 2009 Sep 1.

Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study

Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL.

Neurorehabil Neural Repair. 2010 Jan;24(1):34-41. doi: 10.1177/1545968309341060. Epub 2009 Sep 3.

In situ treatment of an infected intrathecal baclofen pump implant with gentamicin-impregnated collagen fleece

Peerdeman SM, de Groot V, Feller RE.

J Neurosurg. 2010 Jun;112(6):1308-10. doi: 10.3171/2009.8.JNS081692.

Neuromuscular adaptations to eccentric strength training in children and adolescents with cerebral palsy

Reid S, Hamer P, Alderson J, Lloyd D.

Dev Med Child Neurol. 2010 Apr;52(4):358-63. doi: 10.1111/j.1469-8749.2009.03409.x. Epub 2009 Sep 8.

Stop using the Ashworth Scale for the assessment of spasticity

Fleuren JF, Voerman GE, Erren-Wolters CV, Snoek GJ, Rietman JS, Hermens HJ, Nene AV.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):46-52. doi: 10.1136/jnnp.2009.177071. Epub 2009 Sep 21.

Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: grasp strategies and kinematics of reach-to-grasp movements

Bensmail D, Robertson J, Fermanian C, Roby-Brami A.

Neurorehabil Neural Repair. 2010 Feb;24(2):141-51. doi: 10.1177/1545968309347683. Epub 2009 Sep 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias